January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinic ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果